Literature DB >> 9178801

Patients suffering from both Hodgkin's disease and non-Hodgkin's lymphoma: a clinico-pathological and immuno-histochemical population-based study of 32 patients.

R M Amini1, G Enblad, C Sundström, B Glimelius.   

Abstract

The occurrence of Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL) appearing in the same individual indicates a closer relationship between the 2 diseases than previously believed. The purpose of our study was to analyze cases of HD and NHL in a defined population clinically, histopathologically and immunohistochemically to look for similarities indicating a common cellular origin. Between 1974 and 1994, 77 individuals were identified from the Swedish Cancer Registry and the National Health Care Programme for HD as potentially having both diagnoses. Thirty-two patients who had both HD and NHL were available for histo-pathological re-examination and immunohistochemical staining with CD30, CD15, LMP, p53, CD45 (LCA), CD3, CD45R0 (UCHL-1), L26, MB2 and CD45R (4KB5). The most common relation was HD preceding a high-grade malignant NHL (16 of 32 patients), unexpectedly often of T-cell phenotype (7 of 16 patients). The next common association was NHL of B-CLL type followed by HD (7 of 32 patients). At clinical presentation, the first lymphoma did not differ from lymphomas not associated with a second lymphoma, whereas the second one often appeared with a disseminated and aggressive clinical form. There was a significant correlation between the expression of p53 and LMP in first and second lymphomas. CD3 antibody was frequently expressed both in HD and NHL, whereas positivity for B-cell-related antibodies, CD30, CD15 and CD45R0, was less frequent and generally lower than previously described. The occurrence of HD and NHL in an individual is unusual. Tumour biological features common to both HD and NHL may indicate a similar cellular origin, regardless of the time interval between the diagnoses, and may contribute to the understanding of the pathogenesis of lymphoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9178801     DOI: 10.1002/(sici)1097-0215(19970516)71:4<510::aid-ijc2>3.0.co;2-x

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Concurrent Hodgkin's disease (mixed cellularity type) and T-cell chronic lymphocytic leukemia/prolymphocytic leukemia.

Authors:  A Miyata; K Kojima; T Yoshino; S Fujii; K Shinagawa; K Ichimura
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

2.  Three coexisting lymphomas in one patient: genetically related or only a coincidence?

Authors:  M Steinhoff; C Assaf; I Anagnostopoulos; C C Geilen; H Stein; M Hummel
Journal:  J Clin Pathol       Date:  2006-12       Impact factor: 3.411

Review 3.  Relationship between Hodgkin's and non-Hodgkin's lymphomas.

Authors:  Rose-Marie Amini; Gunilla Enblad
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

4.  A case of age-related EBV-associated B-cell lymphoproliferative disorder metachronously showing two distinct morphologic appearances, one of a polymorphic disease resembling classical Hodgkin lymphoma, and the other of a large-cell lymphoma.

Authors:  Tadashi Murase; Ayumi Fujita; Hironori Ueno; Jae-Won Park; Takahiro Yano; Masahiro Hoshikawa; Masayuki Takagi; Shigeru Kuramochi
Journal:  Int J Hematol       Date:  2008-12-18       Impact factor: 2.490

5.  Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma.

Authors:  Sun Hee Chang; Hye Ran Lee
Journal:  Case Rep Oncol Med       Date:  2015-01-13

Review 6.  Second malignancies in Hodgkin's disease: A review of the literature and report of a case with a secondary Lennert's lymphoma.

Authors:  Ernst Jg Norval; Erich J Raubenheimer
Journal:  J Oral Maxillofac Pathol       Date:  2014-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.